BlackRock Inc. Takes $441.69 Million Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• BlackRock acquired a 16.07% stake in Acadia Healthcare, purchasing 14.96 million shares worth approximately $441.7 million during the second quarter.
• Acadia reported quarterly revenue of $865.8 million and EPS of $0.38, exceeding analyst estimates, though revenue declined 0.4% year over year and the company posted a negative net margin.
• Analyst sentiment is mixed: the consensus rating is “Hold” with an average price target of $29.85, while several firms recently raised targets and issued buy or outperform ratings.

BlackRock Inc. bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm bought 14,957,168 shares of the company's stock, valued at approximately $441,685,000. BlackRock Inc. owned 16.07% of Acadia Healthcare as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Acadia Healthcare in the first quarter worth about $1,600,000. Goldman Sachs Group Inc. boosted its holdings in Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company's stock valued at $21,170,000 after acquiring an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company's stock valued at $10,337,000 after acquiring an additional 27,207 shares during the period. American Century Companies Inc. grew its position in Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company's stock worth $2,399,000 after acquiring an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. increased its stake in Acadia Healthcare by 21.9% in the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company's stock worth $225,000 after purchasing an additional 1,780 shares during the period.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $29.87 on Wednesday. The business has a 50 day moving average of $30.14 and a 200 day moving average of $25.81. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83. The company has a market cap of $2.78 billion, a PE ratio of -2.40, a P/E/G ratio of 9.25 and a beta of 0.64. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same period in the previous year, the firm earned $0.83 EPS. The company's quarterly revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on ACHC shares. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a report on Friday, June 12th. TD Cowen upped their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Royal Bank Of Canada increased their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an "outperform" rating in a research report on Monday, May 4th. Jefferies Financial Group raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and raised their price target for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, UBS Group upped their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Acadia Healthcare currently has a consensus rating of "Hold" and an average target price of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source